Genetic tweak optimizes drug-making cells by blocking buildup of toxic byproduct
An international team of researchers led by the University of California San Diego has developed a new strategy to enhance pharmaceutical production in Chinese hamster ovary (CHO) cells, which are commonly used to manufacture protein-based drugs for …